Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization "Track B"

Leanna Levine's Biography

Leanna Levine, President & CEO, ALine, Inc.

Dr. Levine, founder of ALine, Inc. conceived and developed ALine’s unique and proprietary fabrication platform that permits rapid prototyping and volume manufacture of highly functional microfluidic and lab-on-chip devices. Under her leadership, the company has developed instrumentation and a unique tool box of functions that have seen commercial application for single-use products. ALine has created a disposable design strategy that can be generally applied for a variety of multiplexed, quantitative diagnostic or field-portable tests. Prior to founding ALine, Dr. Levine’s lab lead the industry in the application of fluorescence polarization for high throughput screening of enzyme targets, now an industry standard detection method in fluorescent plate readers. In 1998 she joined Spectrum Laboratories as Director of Manufacturing and Product Development where she developed a novel fiber-in-fiber spinning method for hollow fiber membranes. Her unique combination of scientific research skills and manufacturing expertise has played a significant role in creating a bridge from research innovations into viable product opportunities. Dr. Levine earned her PhD at Washington University, St. Louis (1986), and her BS in Biochemistry and BA in German from the University of Missouri, Columbia, MO (1982). In 2003 she was a visiting scholar at the UCLA Anderson School of Business. In 2000 she was the chair of the Gordon Conference on Bioanalytical Sensors. She is the co-author on a dozen publications, and several patents.

Leanna Levine Image

Engineered Microfluidic Components for System Integration: Case Studies and Lessons learned

Wednesday, 3 October 2018 at 11:00

Add to Calendar ▼2018-10-01 13:45:002018-10-01 14:45:00Europe/

Moving quickly from a design to a working benchtop system allows product developers to optimize the analytical triad in microfluidic product development: Cartridge + Instrument + Reagent workflow. In this presentation we provide an overview of our strategies for multi-step assay implementation in a microfluidic platform within 12 weeks, using examples from case studies and highlighting the key lessons learned during the development program.

Monday, 1 October 2018 at 13:45

Add to Calendar ▼2018-10-01 13:45:002018-10-01 14:45:00Europe/

Add to Calendar ▼2018-10-01 00:00:002018-10-03 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization "Track B"